Michael S. Ostrach

2013 - Dynavax Technologies

In 2013, Michael S. Ostrach earned a total compensation of $1.1M as Senior Vice President, Chief Financial Officer and Chief Business Officer at Dynavax Technologies, a 26% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$185,000
Option Awards$561,960
Salary$342,176
Other$3,616
Total$1,092,752

Ostrach received $562K in option awards, accounting for 51% of the total pay in 2013.

Ostrach also received $185K in non-equity incentive plan, $342.2K in salary and $3.6K in other compensation.

Rankings

In 2013, Michael S. Ostrach's compensation ranked 6,208th out of 12,286 executives tracked by ExecPay. In other words, Ostrach earned more than 49.5% of executives.

ClassificationRankingPercentile
All
6,208
out of 12,286
50th
Division
Manufacturing
2,167
out of 4,612
53rd
Major group
Chemicals And Allied Products
642
out of 1,462
56th
Industry group
Drugs
464
out of 1,156
60th
Industry
Pharmaceutical Preparations
372
out of 890
58th
Source: SEC filing on April 22, 2016.

Ostrach's colleagues

We found nine more compensation records of executives who worked with Michael S. Ostrach at Dynavax Technologies in 2013.

2013

Eddie Gray

Dynavax Technologies

Chief Executive Officer

2013

J Martin

Dynavax Technologies

Chief Medical Officer

2013

Dino Dina

Dynavax Technologies

Chief Executive Officer

2013

Stephen Tuck

Dynavax Technologies

Former Vice President, Global Technical Operations

2013

David Novack

Dynavax Technologies

Senior Vice President, Operations and Quality

2013

Robert Coffman

Dynavax Technologies

Chief Scientific Officer

2013

Robert Janssen

Dynavax Technologies

Chief Medical Officer

2013

Jennifer Lew

Dynavax Technologies

Former Vice President, Finance and Former Principal Accounting Officer

2013

Christine Larson

Dynavax Technologies

Chief Financial Officer

News

In-depth

You may also like